Notitia Biotechnologies

Notitia Biotechnologies

Model NM108 - Nutritional Medicine

0

NM108 is an investigational botanical drug that is designed to treat diseases by promoting the growth of either the existing or replenished Foundation Guild™ bacteria in a patient's gut microbiome. NM108 is currently in phase 2 trial as well as available for Expanded Access (compassionate use).

Customer reviews

No reviews were found for Model NM108 - Nutritional Medicine. Be the first to review!